Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;6(3):197-201.
doi: 10.1097/COH.0b013e3283453e16.

Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses

Affiliations
Review

Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses

Philip A Mudd et al. Curr Opin HIV AIDS. 2011 May.

Abstract

Purpose of review: We will summarize recent advances in research regarding control of simian immunodeficiency virus replication in nonhuman primate models. We will then relate these findings to the broader field of human immunodeficiency virus (HIV) vaccine development.

Recent findings: Recent studies have highlighted the importance of T-cell responses in elite control, especially CD8+ T-cell responses and provide insight into the kinetics and qualities of such effective responses. Additionally, these findings suggest that the peptides bound by elite control-associated major histocompatibility complex class I molecules in monkeys and humans share many properties.

Summary: Animal models of effective immune control of immunodeficiency virus replication have provided important insight into the components of successful immune responses against these viruses. Similarities between the human and nonhuman primate responses to immunodeficiency viruses should help us understand the nature of elite control. Further study of the acute phase, in which virus replication is first brought under control, may help define important characteristics of viral control that could be engendered by a successful HIV vaccine.

PubMed Disclaimer

References

    1. Johnston MI, Fauci AS. An HIV vaccine--challenges and prospects. N Engl J Med. 2008;359:888–890. - PubMed
    1. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A. 2000;972:709–2714. - PMC - PubMed
    1. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317:944–947. - PMC - PubMed
    1. The International HIV Controllers Study The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation. Science. 2010;330:1551–1557. - PMC - PubMed
    1. Yant LJ, Friedrich TC, Johnson RC, et al. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol. 2006;80:5074–5077. - PMC - PubMed

MeSH terms